GURUFOCUS.COM » STOCK LIST » Technology » Software » Sinopharm Tech Holdings Ltd (HKSE:08156) » Definitions » PS Ratio

Sinopharm Tech Holdings (HKSE:08156) PS Ratio : 0.43 (As of May. 27, 2024)


View and export this data going back to 2002. Start your Free Trial

What is Sinopharm Tech Holdings PS Ratio?

The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. As of today, Sinopharm Tech Holdings's share price is HK$0.11. Sinopharm Tech Holdings's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 was HK$0.26. Hence, Sinopharm Tech Holdings's PS Ratio for today is 0.43.

The historical rank and industry rank for Sinopharm Tech Holdings's PS Ratio or its related term are showing as below:

HKSE:08156' s PS Ratio Range Over the Past 10 Years
Min: 0.38   Med: 24.08   Max: 124.24
Current: 0.43

During the past 13 years, Sinopharm Tech Holdings's highest PS Ratio was 124.24. The lowest was 0.38. And the median was 24.08.

HKSE:08156's PS Ratio is ranked better than
89.35% of 2751 companies
in the Software industry
Industry Median: 2.28 vs HKSE:08156: 0.43

Sinopharm Tech Holdings's Revenue per Sharefor the three months ended in Dec. 2023 was HK$0.08. Its Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 was HK$0.26.

Warning Sign:

Sinopharm Tech Holdings Ltd revenue per share has been in decline for the last 5 years.

During the past 12 months, the average Revenue per Share Growth Rate of Sinopharm Tech Holdings was 3.70% per year. During the past 3 years, the average Revenue per Share Growth Rate was -38.50% per year. During the past 5 years, the average Revenue per Share Growth Rate was -2.30% per year. During the past 10 years, the average Revenue per Share Growth Rate was -5.10% per year.

During the past 13 years, Sinopharm Tech Holdings's highest 3-Year average Revenue per Share Growth Rate was 70.50% per year. The lowest was -48.30% per year. And the median was -13.60% per year.

Back to Basics: PS Ratio


Sinopharm Tech Holdings PS Ratio Historical Data

The historical data trend for Sinopharm Tech Holdings's PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sinopharm Tech Holdings PS Ratio Chart

Sinopharm Tech Holdings Annual Data
Trend Jun14 Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23
PS Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 20.24 4.77 14.93 13.16 1.50

Sinopharm Tech Holdings Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
PS Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3.46 4.17 1.50 0.61 0.52

Competitive Comparison of Sinopharm Tech Holdings's PS Ratio

For the Software - Application subindustry, Sinopharm Tech Holdings's PS Ratio, along with its competitors' market caps and PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Sinopharm Tech Holdings's PS Ratio Distribution in the Software Industry

For the Software industry and Technology sector, Sinopharm Tech Holdings's PS Ratio distribution charts can be found below:

* The bar in red indicates where Sinopharm Tech Holdings's PS Ratio falls into.



Sinopharm Tech Holdings PS Ratio Calculation

The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. It is a ratio widely used to value stocks and it was first used by Ken Fisher.

Sinopharm Tech Holdings's PS Ratio for today is calculated as

PS Ratio=Share Price/Revenue per Share (TTM)
=0.11/0.255
=0.43

Sinopharm Tech Holdings's Share Price of today is HK$0.11.
Sinopharm Tech Holdings's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was HK$0.26.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

PS Ratio=Market Cap/Revenue

The Revenue here is for the trailing 12 months.


Sinopharm Tech Holdings  (HKSE:08156) PS Ratio Explanation

The PS Ratio is an excellent valuation indicator if you want to compare a stock with its historical valuation or with the stocks in the same industry. The PS Ratio works especially well when you want to compare the stock's current valuation with its historical valuation. The PS Ratio is a great valuation tool for evaluating cyclical businesses where the PE Ratio works poorly. It works the best when comparing the current valuation with the historical valuation because over time, a company's profit margin tends to revert to the mean.

When the PS Ratio is applied to the whole stock market, it can be used to evaluate the current market valuation and projected returns. In this case, the price is the total market cap of all stocks that are traded, and sales are the GDP of the country. This is how Warren Buffett estimates the broad market valuation and project future returns.

Similar to the PE Ratio or Price-to-Operating-Cash-Flow or Price-to-Free-Cash-Flow , the PS Ratio measures the valuation based on the earning power of the company. This is where it is different from the PB Ratio , which measures the valuation based on the company's balance sheet.


Be Aware

The PS Ratio does not tell you how cheap or expensive the stock is. It cannot be used to compare companies in different industries. It works better for companies within the same industry because these companies tend to have similar capital structures and profit margins. It works the best when comparing a company with itself in the past.


Sinopharm Tech Holdings PS Ratio Related Terms

Thank you for viewing the detailed overview of Sinopharm Tech Holdings's PS Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Sinopharm Tech Holdings (HKSE:08156) Business Description

Traded in Other Exchanges
N/A
Address
Ruttonjee Centre, 11 Duddell Street, Unit 1802, 18/F, Ruttonjee House, Hong Kong Central, Hong Kong, HKG
Sinopharm Tech Holdings Ltd is an investment holding company. The company's operating segment includes Lottery-related services; Provision of Internet Plus services (solution and supply chain), Manufacturing and distribution of personal protective equipment, and Others services. It generates maximum revenue from the internet plus services (solution and supply chain) segment. The Internet plus Supply chain services segment includes the provision of supply chain management, data analysis and related services, and trading of goods through the internet platform. Geographically, it derives a majority of revenue from Hong Kong.
Executives
Best Frontier Investments Limited
Chan Kin Ho Philip 2201 Interest of corporation controlled by you
Lam Yui Keung 2201 Interest of corporation controlled by you
Sinopharm Traditional Chinese Medicine Overseas Holdings Limited 2101 Beneficial owner
Main Key Investments Limited 2201 Interest of corporation controlled by you
Guo Lei 2201 Interest of corporation controlled by you
Integrated Asset Management (asia) Limited 2101 Beneficial owner
Yam Tak Cheung 2201 Interest of corporation controlled by you
Chan Tung Mei 2202 Interest of your spouse
Cheung Kwai Lan 2201 Interest of corporation controlled by you
Tse Siu Hoi 2101 Beneficial owner
Gam Star China Equity (a Sub-fund Of Gam Star Fund P.l.c.) 2102 Investment manager

Sinopharm Tech Holdings (HKSE:08156) Headlines

No Headlines